Studies have shown that cell surface mucin 13 ( MUC13) protects the degradation of β-catenin by interacting with GSK-3β, thereby increasing the nuclear translocation of β-catenin and promoting the occurrence, development, invasion and immunosuppression of cancer by signaling transduction [6]. The gene discussed is MUC13; the disease is cancer.